News - 2006
 
 
September 21, 2006: Cardinal Health to Collaborate with Wyeth on Cell Line Development "Patented GPEx® Technology will be used to Engineer Cell Lines Expressing Wyeth Biopharmaceutical Molecules"
September 12, 2006: Cardinal Health To Collaborate With Trubion On A Novel Class Of Biopharmaceuticals "Patented GPEx® Technology to Be Used to Engineer Cell Lines Expressing a Proprietary Trubion SMIP™ Molecule"
January 6, 2006: Cardinal Health To Collaborate With Centocor On Cell-line Development.
"Patented GPEx® Technology will be used to Engineer Cell Lines Expressing Monoclonal Antibodies" PDF version
   
   
   
 
 
Home About Us Gala Capabilities Working with Gala Employment News Contact Us galainfo@catalent.com